Navigation Links
Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of Pol I as New Approach to Cancer Therapy
Date:7/10/2012

ac later this year."

The Cancer Cell publication highlighted a number of potential competitive advantages of CX-5461.  An unanticipated finding was that malignant cells are considerably more dependent upon maintenance of high levels of Pol I activity than previously believed, and even modest inhibition of Pol I triggers cancer cell death. These results suggest that selective activation of a surveillance pathway to activate p53, using Pol I inhibitors such as CX-5641, is likely to be therapeutically useful in the treatment of a wide range of tumors. In addition, as a cancer-specific inducer of p53, CX-5461 was shown to be 300 times more potent than currently studied non-genotoxic p53 activators with alternate mechanisms.

About Pol I and CX-5461 CX-5461 is a first-in-class, selective small molecule inhibitor of RNA polymerase I (Pol I) that triggers a stress surveillance pathway to activate p53 in cancer cells. The tumor suppressor protein p53, known as "the guardian of the genome," orchestrates cellular responses to diverse stress factors. Activation of this protein can lead to cell cycle arrest or cell death and it is pivotal in determining whether cancer cells proliferate or die. CX-5461 inhibits upregulated Pol I transcription in cancer cells, causing the release of ribosomal proteins (RP) from the nucleolus. These RP then bind to Mdm2, liberating p53 from the Mdm2-p53 complex to induce apoptosis in cancer cells. Non-genotoxic activation of p53 has long been an attractive approach to treating cancers, but it has not yet been successfully exploited in the clinic. CX-5461 has therapeutic potential in both solid tumor and hematological malignancies, yet hematologic cancers, the vast majority of which have wild-type p53 status, are exquisitely sensitive to CX-5461 and represent the clearest path to clinical proof of concept.

About Cylene Pharmaceuticals Cylene Pharmaceuticals is a clinical stage private company developing small molecu
'/>"/>

SOURCE Cylene Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
2. Oncos Therapeutics Announces Clinical Advisory Board for its Oncolytic Virus and Cancer Immunotherapy Development Programs
3. Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
4. Global Kidney Cancer Drugs Industry
5. Trovagene to Study Trans-Renal KRAS Mutation Detection in Pancreatic Cancer
6. Prostate Cancer Center of New Jersey the Latest Center to Achieve High Honor of ACR-ASTRO Accreditation
7. Lifeline Biotechnologies, Inc. Receives Patent Award, a Device for Breast Tissue Temperature Analysis for Determining Cancer Conditions
8. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
9. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
10. Elektas Gamma Knife and Radiation Therapy Systems for Cancer Treatment Take Top Three Places in 2012s Best in KLAS for Radiation Therapy
11. Healthscope to commercially launch Circadians Cancers of Unknown Primary Diagnostic Test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... Corporation (NYSE: HAE ) announced today that ... present at The Deutsche Bank 38 th Annual dbAccess ... on May 29, 2013 at 1:30pm Eastern time.  ... may access Mr. Lindop,s presentation live via webcast at: ... (NYSE: HAE ) is a global healthcare company ...
(Date:5/23/2013)... KNOXVILLE, Tenn. , May 23, 2013 /PRNewswire/ ... of 24-hour nurse triage and nurse advice lines, ... 10-person committee, comprising physician, nursing and administrative leaders, ... providing safe, quality and cost-effective services for hospital ... "As our national healthcare system evolves, it,s imperative ...
(Date:5/23/2013)... Mich. , May 23, 2013  Every day, their ... of air to his lungs. April and Bryan ... dire predictions weren,t true. "Quite a few doctors ... hospital alive," says April Gionfriddo , about ... desperate. Anything that would work, we would take it and ...
Breaking Medicine Technology:TeamHealth Medical Call Center Forms Clinical Advisory Committee 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 2Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 3Baby's life saved with groundbreaking 3D printed device from U-M that restored his breathing 4
... 12, 2011 Southern Home Medical Equipment, Inc. ... healthcare professionals and equipment to medical institutions, announced ... operations for fiscal year 2010 have been restated ... Medical Staffing. In a previous announcement ...
... Inc., a privately held medical device company focused on ... announced the initial launch of its Durango™ Stand-Alone ALIF ... was made at the 2011 American Association of Neurological ... The Durango system is intended to treat degenerative disc ...
Cached Medicine Technology:Southern Home Medical Equipment Reports Additional Revenues and Profits for 2010 2Lanx®, Inc. Launches Durango™ Stand-Alone ALIF System 2
(Date:5/24/2013)... Drugs commonly used to treat glaucoma may cause droopy ... vision, according to a new study. The drugs, ... reduce eye pressure, have already been shown to cause ... researchers said, suggesting that the new findings could lead ... be conservative when prescribing these drugs, the researchers added, ...
(Date:5/24/2013)... New York, New York (PRWEB) May 24, 2013 ... naturally white teeth. It is not uncommon for the majority ... natural teeth. Whether it is due to a coffee addiction ... this is why whitening procedures are so popular. ... of a new and very effective whitening system: Venus White ...
(Date:5/24/2013)... May 24, 2013 Area homeowners dreaming about ... new hot tubs to choose from at factory-direct pricing during ... The sales event takes place at Emerald Pool and ... , Jacuzzi, the industry's leading hot tub brand, scheduled ... the country. The event will feature popular hot tub models ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 The nation’s ... involving Intuitive Surgical Inc.’s da Vinci Surgical System concluded ... records, a Washington State Court jury ruled in a ... training a surgeon who performed a da Vinci prostatectomy ... The patient’s family had alleged in their lawsuit that ...
(Date:5/24/2013)... Two mutations central to the development of infantile myofibromatosis ... bone, and soft tissuemay provide new therapeutic targets, according ... Mount Sinai. The findings, published in the American ... treatment options for this debilitating disease, for which the ... the tumors. , IM is an inheritied disorder that ...
Breaking Medicine News(10 mins):Health News:Common Glaucoma Drug May Cause Droopy Eyelids, Study Finds 2Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2
... but are prepared to try and lessen the number of ... studying healthcare literature, a team of Cochrane Researchers could find ... of cutting down the number of cigarettes. ,The ... helping them to stop smoking completely. But, little thought has ...
... it doesnt come cheap. But the new bionic hand, developed by a ... , ,It can't click its fingers or play the ... ,It can, for instance, turn a key in a lock, hold ... , ,David Gow who works with with Lothian NHS in ...
... Researchers have revealed that combining a non-pyrethroid insecticide, ... to be an effective insecticide-repellent synergy against ... ,A combination of the two had proved ... addition of their respective properties. Mosquito nets soaked ...
... a 10 million dollar specialist cancer hospital which will enable ... . ,Mwanawasa said the National Cancer Diseases Hospital ... cancer patients in Zambia who have previously had to be ... average 10,000 dollars per person. ,"Treatment at the ...
... with the U.K.-based Oxford Brookes University, has opened a ... ,For the people of the city that subsist ... development. For now scientific testing methodology is generating enough ... which food is converted into blood glucose) to prompt ...
... the premier institute of medicine AIIMS and has been asked ... State Consumer Commission . ,All India Institute of Medical ... cancer patient and removing her breast as a part of ... by Justice J D Kapoor held the hospital guilty of ...
Cached Medicine News:Health News:Chain Smokers Prepared to Lessen Their Daily Cigs Rather Than Quitting 2Health News:Scottish Engineer Devises Versatile Hand 2Health News:Insecticide and Repellent Combo Effective in Eliminating Malarial Mosquitoes 2Health News:A Centre for Glycemic Index Testing Opened in Chennai 2Health News:AIIMS Fined Rs 5 Lakhs for Negligence 2
... is made of two probes which are ... sensor distance., ,VersaFlex disposable catheters for ... VersaFlex catheters are the smallest diameter esophageal ... are the perfect combination of flexibility and ...
... Slimline multi-use catheters are designed ... solution with the following benefits:, ... reference: ,In procedures where the multi-use ... Gel creates stable contact to the ...
FLEXILOG accessory....
FLEXILOG spare part....
Medicine Products: